TY - JOUR
T1 - Glucagonocentric restructuring of diabetes
T2 - A pathophysiologic and therapeutic makeover
AU - Unger, Roger H
AU - Cherrington, Alan D.
PY - 2012/1/3
Y1 - 2012/1/3
N2 - The hormone glucagon has long been dismissed as a minor contributor to metabolic disease. Here we propose that glucagon excess, rather than insulin deficiency, is the sine qua non of diabetes. We base this on the following evidence: (a) glucagon increases hepatic glucose and ketone production, catabolic features present in insulin deficiency; (b) hyperglucagonemia is present in every form of poorly controlled diabetes; (c) the glucagon suppressors leptin and somatostatin suppress all catabolic manifestations of diabetes during total insulin deficiency; (d) total β cell destruction in glucagon receptor-null mice does not cause diabetes; and (e) perfusion of normal pancreas with anti-insulin serum causes marked hyperglucagonemia. From this and other evidence, we conclude that glucose- responsive β cells normally regulate juxtaposed α cells and that without intraislet insulin, unregulated α cells hypersecrete glucagon, which directly causes the symptoms of diabetes. This indicates that glucagon suppression or inactivation may provide therapeutic advantages over insulin monotherapy.
AB - The hormone glucagon has long been dismissed as a minor contributor to metabolic disease. Here we propose that glucagon excess, rather than insulin deficiency, is the sine qua non of diabetes. We base this on the following evidence: (a) glucagon increases hepatic glucose and ketone production, catabolic features present in insulin deficiency; (b) hyperglucagonemia is present in every form of poorly controlled diabetes; (c) the glucagon suppressors leptin and somatostatin suppress all catabolic manifestations of diabetes during total insulin deficiency; (d) total β cell destruction in glucagon receptor-null mice does not cause diabetes; and (e) perfusion of normal pancreas with anti-insulin serum causes marked hyperglucagonemia. From this and other evidence, we conclude that glucose- responsive β cells normally regulate juxtaposed α cells and that without intraislet insulin, unregulated α cells hypersecrete glucagon, which directly causes the symptoms of diabetes. This indicates that glucagon suppression or inactivation may provide therapeutic advantages over insulin monotherapy.
UR - http://www.scopus.com/inward/record.url?scp=84855459920&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855459920&partnerID=8YFLogxK
U2 - 10.1172/JCI60016
DO - 10.1172/JCI60016
M3 - Review article
C2 - 22214853
AN - SCOPUS:84855459920
SN - 0021-9738
VL - 122
SP - 4
EP - 12
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 1
ER -